z-logo
open-access-imgOpen Access
Specific enzyme immunoassay for a‐fetoprotein from hepatocellular carcinoma
Author(s) -
Kohno Takeyuki,
Ishikawa Eiji,
Kitamura Tooru,
Tsuda Kazunori
Publication year - 1990
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.1860040114
Subject(s) - immunoassay , hepatocellular carcinoma , carcinoma , enzyme , chemistry , medicine , cancer research , biochemistry , antibody , immunology
α‐Fetoprotein in sera from healthy subjects and patients with liver cirrhosis and hepatocellular carcinoma was fractionated into three peaks by affinity chromatography on a column of Lens culinaris agglutinin‐Sepharose 48. One peak (the first peak) was found in all the serum samples, but the other two peaks (the second and third peaks) were found only in patients with hepatocellular carcinoma. For α‐fetoprotein in the second and third peaks, a specific enzyme immunoassay was developed. Lens culinaris agglutinin‐coated polystyrene balls were incubated with α‐fetoprotein and, after washing, with affinity‐purified anti‐a‐fetoprotein Fab'‐β‐D‐galactosidase conjugate. β‐D‐galactosidase activity bound to the polystyrene balls was assayed by fluorsimetry. The maximal volume of serum that could be used without interference was 0.2 m̈l, and the minimal detectable serum concentrations of α‐fetoprotein in the second and third peaks were 3.5 mg/liter and 0.1 mg/liter, respectively. The maximal serum concentration of α‐fetoprotein in the first peak that did not affect the detection limits of a‐fetoprotein in the second and third peaks was 10 mg/liter. It was possible to confirm the presence of a‐fetoprotein in the second and third peaks by a significant difference between bound β‐D‐galactosidase activities in the absence and presence of α‐methyl‐D‐mannoside or D‐glucose. This assay may be useful for diagnosis of hepatocellular carcinoma, although further improvements remain to be made.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here